Invesco (IVZ) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Jan 26, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Phoebe A. Wood, Director sold 3,000 shares at $32.44 ($97K).
- Trade date
- Sep 11, 2026
- Disclosed to the SEC
- Sep 14, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All IVZ insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
IVZ insider transactions (Form 4)
Open-market purchases and sales. 67 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 14SEC | Phoebe A. WoodDirector | Sell | 3,000107,111 held (−3%) | $32.44 | $97K | -13.3% | — |
| Sep 10SEC | Andrew Tak Shing LoSenior Managing Director | Sell | 100,840812,477 held (−11%) | $32.20 | $3.2M | -12.7% | — |
| Sep 10SEC | Stephanie ButcherSenior Managing Director | Sell | 45,09510,205 held (−82%) | $32.28 | $1.5M | -12.9% | — |
| Sep 10SEC | Andrew Tak Shing LoSenior Managing Director | Sell | 42,530913,317 held (−4%) | $32.84 | $1.4M | -14.4% | — |
| Sep 9SEC | Laura Allison DukesCFO | Sell | 31,075259,183 held (−11%) | $33.16 | $1.0M | -15.2% | — |
| Nov 3SEC | Douglas J. SharpSenior Managing Director | Sell | 160,000192 held (sold 99.9%) | $23.56 | $3.8M | +19.4% | — |
Similar past setups: not applicable. IVZ has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with IVZ in the Research Lab
IVZ has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Invesco insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $7.2M of IVZ stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
IVZ insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $7.2M | 5 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $3.8M | 1 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Invesco insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $7.2M. Among insiders with enough purchase history to measure, Thomas M. Finke (Director) has the highest Insider Score at 3. 0 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
IVZ earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 27, 2026 | -4.1% | None | +0.5%S&P +0.9% | pending |
| Jul 28, 2026 | +3.9% | None | -6.8%S&P -1.3% | +17.8% |
| Apr 28, 2026 | +8.1% | None | +0.6%S&P -0.5% | +11.9% |
| Jan 27, 2026 | +0.2% | None | -3.7%S&P +0.4% | -3.9% |
| Oct 28, 2025 | +4.4% | None | +2.7%S&P +0.3% | +2.3% |
| Jul 22, 2025 | +20.7% | None | +6.1%S&P +0.9% | +1.5% |
| Apr 22, 2025 | -2.7% | None | +8.4%S&P +4.2% | +7.9% |
| Jan 28, 2025 | +8.5% | None | +7.0%S&P +0.4% | -7.4% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
IVZ short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded IVZ
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.House · D-CA | Sold $1,001 - $15,000 | Feb 10, 2026 | Mar 9, 2026 | +5.4% |
| Gilbert Ray Cisneros, Jr.House · D-CA | Bought $1,001 - $15,000 | Jan 9, 2026 | Feb 13, 2026 | +0.6% |
Insiders at Invesco
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Andrew Tak Shing LoSenior Managing Director | — | $4.6M | Sep 10, 2026 | — | — |
| Douglas J. SharpSenior Managing Director | — | $3.8M | Sep 2, 2026 | — | — |
| Stephanie ButcherSenior Managing Director | — | $1.5M | Sep 10, 2026 | — | — |
| Laura Allison DukesCFO | — | $1.0M | Sep 9, 2026 | — | — |
| Phoebe A. WoodDirector | — | $97K | Sep 14, 2026 | — | — |
| Shannon A. JohnstonSmd And Cioo | — | — | Oct 20, 2026 | — | — |
| Andrew SchlossbergCEO, President | — | — | Jul 7, 2026 | — | — |
| Jeffrey H. KuporSenior Managing Director | — | — | Jul 7, 2026 | — | — |
| G. Richard Wagoner Jr.Director | — | — | May 19, 2026 | — | — |
| Christopher C. WomackDirector | — | — | May 19, 2026 | — | — |
| Thomas P. GibbonsDirector | — | — | May 19, 2026 | — | — |
| William Francis Glavin Jr.Director | — | — | May 19, 2026 | — | — |
| Thomas M. FinkeDirector | — | — | May 19, 2026 | 1 of 1 | 3 |
| Nigel SheinwaldDirector | — | — | May 19, 2026 | — | — |
| Sarah BesharDirector | — | — | May 19, 2026 | — | — |
| Paula TolliverDirector | — | — | May 19, 2026 | — | — |
| Elizabeth S. JohnsonDirector | — | — | May 19, 2026 | — | — |
| Alan Leonard SmithSmd And Chro | — | — | Mar 17, 2026 | — | — |
| Tony WongSenior Managing Director | — | — | Mar 3, 2026 | — | — |
| Terry VacheronChief Accounting Officer | — | — | Mar 3, 2026 | — | — |
Board links: companies that share insiders with IVZ
Directors and executives who filed Form 4s for IVZ and another company in the last 12 months.
- SOSouthern Christopher C. Womack Director here · CEO, President at SO · latest filing May 26, 2026
- VENUVenu Holding Thomas M. Finke Director here · Director at VENU · latest filing Oct 1, 2026
Insider activity at other Financials companies
Same sector, ranked by insider buying in the last 90 days.
IVZ stock: common questions
Are Invesco insiders buying IVZ stock?
No. No Invesco insider reported an open-market purchase of IVZ in the past 12 months.
Are Invesco insiders selling IVZ stock?
4 insiders reported sales worth $7.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IVZ's 52-week range?
Over the past year IVZ has traded between $22.20 and $33.31. It last closed at $28.11 on Nov 19, 2026.